Pages with the fewest revisions
Showing below up to 50 results in range #151 to #200.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Protein HEG homolog 1 (1 revision)
- Selenoprotein P (1 revision)
- Galectin-3-binding protein (1 revision)
- Heat shock cognate 71 kDa protein (1 revision)
- TG2 reactive residues (Ubiquitin) (1 revision)
- Histone H3.1 (1 revision)
- Apolipoprotein A-II (1 revision)
- Plasma protease C1 inhibitor (1 revision)
- Protein MENT (1 revision)
- Complement component C6 (1 revision)
- Desmoplakin (1 revision)
- Small proline rich proteins SPRs-2 (1 revision)
- Heat shock protein beta-6 (1 revision)
- Hyaluronan-binding protein 2 (1 revision)
- Insulin-like growth factor-binding protein-3 (1 revision)
- Neurogenic locus notch homolog protein 2 (1 revision)
- Peptidase inhibitor 16 (1 revision)
- Plasminogen (1 revision)
- Coagulation factor XIII B chain (1 revision)
- Complement component C7 (1 revision)
- Fibrinogen beta chain (1 revision)
- Hemoglobin subunit alpha (1 revision)
- Histone octamer (kinase) (1 revision)
- Calreticulin (1 revision)
- Complement component C8 beta chain (1 revision)
- Fibrinogen gamma chain (1 revision)
- Carboxypeptidase B2 (2 revisions)
- S100A10 (2 revisions)
- Seminal vesicle secretory protein 3 (2 revisions)
- Small proline rich proteins SPRs-3 (2 revisions)
- Hornerin (2 revisions)
- Alpha lactalbumin (2 revisions)
- Bcl-2 homologous antagonist/killer (2 revisions)
- C-1-tetrahydrofolate synthase (2 revisions)
- Peroxiredoxin-1 (2 revisions)
- TG2 reactive residues (Annexin I) (2 revisions)
- Adhesion G-protein coupled receptor G1 (2 revisions)
- Plasmodium falciparum liver stage antigen-1 (2 revisions)
- Dispase autolysis inducing protein (DAIP) (2 revisions)
- Fibronectin (2 revisions)
- Hsp27 (2 revisions)
- Adipocyte plasma membrane-assoiated protein (2 revisions)
- S100A11 (2 revisions)
- Ser/Thr protein phosphatase 2A (2 revisions)
- Myoferlin (2 revisions)
- Nucleophosmin (2 revisions)
- Caspase-3 (2 revisions)
- Collagen alpha-1 (XVIII) (2 revisions)
- Serine protease inhibitor Kazal-type 6 (2 revisions)
- TG2 reactive residues (Plasminogen) (2 revisions)
